Mark J. Sarnak mostly deals with Internal medicine, Kidney disease, Renal function, Risk factor and Endocrinology. His Internal medicine study incorporates themes from Surgery and Cardiology. His Kidney disease research incorporates themes from Nephropathy, Cause of death, Blood pressure, Intensive care medicine and Kidney.
Mark J. Sarnak works mostly in the field of Renal function, limiting it down to topics relating to Cholesterol and, in certain cases, Urine. His study in Risk factor is interdisciplinary in nature, drawing from both Cohort study, Anemia, Disease, Vascular disease and Heart disease. His work deals with themes such as Gastroenterology and Confidence interval, which intersect with Endocrinology.
His primary areas of study are Internal medicine, Kidney disease, Renal function, Endocrinology and Cardiology. Internal medicine is closely attributed to Gastroenterology in his work. His Kidney disease research is multidisciplinary, incorporating perspectives in Nephrology, Surgery, Intensive care medicine, Disease and Kidney.
The various areas that Mark J. Sarnak examines in his Renal function study include Creatinine, Heart failure and Diabetes mellitus. His research in Endocrinology tackles topics such as Cohort study which are related to areas like Cohort. The study incorporates disciplines such as Anemia and Epidemiology in addition to Risk factor.
Mark J. Sarnak mainly investigates Internal medicine, Kidney disease, Renal function, Cardiology and Hazard ratio. His Internal medicine study frequently draws connections between adjacent fields such as Endocrinology. His Kidney disease study integrates concerns from other disciplines, such as Blood pressure, Intensive care medicine, Disease, Kidney and Risk factor.
His Renal function study combines topics from a wide range of disciplines, such as Creatinine, Urine, Diabetes mellitus and Urology. Mark J. Sarnak interconnects Stroke, White matter and Kidney transplantation in the investigation of issues within Cardiology. His studies deal with areas such as Oncology and End stage renal disease as well as Hazard ratio.
His primary areas of investigation include Kidney disease, Internal medicine, Renal function, Risk factor and Diabetes mellitus. His studies in Kidney disease integrate themes in fields like Dialysis, Intensive care medicine, Blood pressure and Cardiology. His study ties his expertise on Endocrinology together with the subject of Internal medicine.
His Renal function research includes themes of Hazard ratio, Confidence interval, Disease, Creatinine and Cohort. His work carried out in the field of Risk factor brings together such families of science as Epidemiology, Cognitive test, Neurocognitive, Physical therapy and Pediatrics. His research investigates the connection between Diabetes mellitus and topics such as Nephrology that intersect with problems in Montreal Cognitive Assessment, Logistic regression, Decreased glomerular filtration rate and Tubulointerstitial fibrosis.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Clinical epidemiology of cardiovascular disease in chronic renal disease.
Robert N. Foley;Patrick S. Parfrey;Mark J. Sarnak.
American Journal of Kidney Diseases (1998)
Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.
Mark J. Sarnak;Andrew S. Levey;Anton C. Schoolwerth;Josef Coresh.
Cystatin C and the risk of death and cardiovascular events among elderly persons.
Michael G. Shlipak;Mark J. Sarnak;Ronit Katz;Linda F. Fried.
The New England Journal of Medicine (2005)
Epidemiology of cardiovascular disease in chronic renal disease.
R N Foley;P S Parfrey;M J Sarnak.
Journal of The American Society of Nephrology (1998)
CHRONIC KIDNEY DISEASE AS A RISK FACTOR FOR CARDIOVASCULAR DISEASE AND ALL-CAUSE MORTALITY: A POOLED ANALYSIS OF COMMUNITY-BASED STUDIES
Daniel E. Weiner;Hocine Tighiouart;Manish G. Amin;Paul C. Stark.
Journal of The American Society of Nephrology (2004)
Atherosclerotic cardiovascular disease risks in chronic hemodialysis patients
Alfred K. Cheung;Mark J. Sarnak;Guofen Yan;Johanna T. Dwyer.
Kidney International (2000)
K/DOQI Clinical Practice Guidelines on Hypertension and Antihypertensive Agents in Chronic Kidney Disease
Andrew S. Levey;Michael V. Rocco;Sharon Anderson;Sharon P. Andreoli.
American Journal of Kidney Diseases (2004)
Reduced kidney function and anemia as risk factors for mortality in patients with left ventricular dysfunction.
Amin Al-Ahmad;William M Rand;Guruprasad Manjunath;Marvin A Konstam.
Journal of the American College of Cardiology (2001)
Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community.
Guruprasad Manjunath;Hocine Tighiouart;Hassan N. Ibrahim;Bonnie MacLeod.
Journal of the American College of Cardiology (2003)
Cardiovascular disease and chronic renal disease: a new paradigm.
Mark J. Sarnak;Andrew S. Levey.
American Journal of Kidney Diseases (2000)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: